In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PTO user fees to be devoted solely to agency after FY 1998 under budget agreement.

Executive Summary

PTO USER FEE SURCHARGE TO END AFTER FY 1998 UNDER BUDGET AGREEMENT reached between Congressional Republicans and the White House, Senate Judiciary Committee Chairman Hatch (R-Utah) reported at a May 7 hearing on Hatch's Omnibus Patent Act of 1997 (S 507). "I have been working with the Chairman of the Senate Budget Committee, Sen. Domenici [R-N.M.] to make certain that the surcharge is not extended," Hatch said. "I am happy to say that the budget agreement announced last week envisions an end to the surcharge after fiscal year 1998 and I will continue to be vigilant to ensure that does not change."

Latest Headlines
See All
UsernamePublicRestriction

Register

PS030198

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel